SUBSCRIBE
SUBSCRIBE
News   Policy

Pfizer Slams Dissident Executive

October 19, 2005 | 
1 min read

Pharmaceutical giant Pfizer has issued a letter slamming one of its senior executives for participating in a pro-drug importation rally with a group of U.S. senators, claiming he is unqualified to comment on the issue.

Legal Regulatory
Pfizer
MORE ON THIS TOPIC
Close-Up Of Medicine Bottles Against Green Background
Opinion
FDA Faces Challenging Decision on Biomarker-Based Label Restrictions
March 10, 2025
 · 
5 min read
 · 
Harpreet Singh
A scientist with pill bottles in front of FDA headquarters
Regulatory
FDA Action Alert: GSK, Alnylam, Sanofi and More
March 10, 2025
 · 
7 min read
 · 
Tristan Manalac
Editorial
FDA Weathers Bait-and-Switch Storm as Staff and Sites Come and Go
March 7, 2025
 · 
3 min read
 · 
Jef Akst
Composite photo collage of hand hold magnifier glass research examine secret object question mark secret isolated on painted background.
Editorial
This Might Be a Moot Point but the FDA’s Priority Review Vouchers Need Transparency
March 7, 2025
 · 
3 min read
 · 
Annalee Armstrong